Testing effectiveness (Phase 2)Looking for participantsNCT05626114
What this trial is testing
Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Who this might be right for
Geographic Atrophy
Genentech, Inc. 60